Browse treatments

…en 2020-2023 and received chemo/IO. Among patients treated with immunotherapy, 563 (87.4%) received atezolizumab; 61 (9.5%) received durvalum…

…, Ribas A. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell. 2017;168:707–723.Chowell D, Yoo S-K, Valero C, Pastore A…

…clinical trial: stalemate or new game strategy for glioblastoma immunotherapy? JAMA Oncology 2020;6. Preprint at https://doi.org/10.1001/jama…

…d additionally showed that this sensitizes RAS mutant tumors to immunotherapy.Results BRAF inhibitors hyperactivated ERK signaling resulting …

… IL32, THY1 and ADGRG2 gradually increased during the course of immunotherapy, whereas IL6, NOS2, CXCL8, S100A12, COPB2 exhibited sustained u…

…ty, and improved immune responses. In summary, the advantage of immunotherapy diminished progressively with age. ICIs were associated with fa…

…ne transitions from Co-based therapy to intensity-modulated RT (IMRT).Between 2021 and 2024, the number of medical physicists increa…

…Background Immunotherapy is considered a promising treatment approach for advanced bilia…

…proofreading (LOP) POLE mutations are associated with favorable immunotherapy response.Methods This retrospective cohort study included a pan…

…stroma to sensitise microsatellite stable colorectal tumours to immunotherapy.…

…types was used to impute subtypes in a second NSCLC cohort with immunotherapy outcomes (N=205).Results METex14 tumors had more inflamed pheno…

…ved spatial features enabled prediction of trastuzumab response.Immunotherapy (IO) response prediction: In the Histo-Miner CPI dataset,3 Hist…